Quote:
Originally Posted by BreezyRacer
Genentech recently bought up 11,000 Parkinson's DNA patient records from 23andme, perhaps connected?
I understand that they are also going to go back and run a complete DNA test on participating volunteers and extend DNA tests to some family members too.
I saw this on a video on the 23andme site ..
|
Interesting observation Breezy. Genentech didn't actually buy the DNA records. They licensed the rights to use the records of approximately 3,000 PD patients in their data base to attempt to identify new therapeutic targets for the disease. 23andme has already used the same new drug model with Pfizer for the search for Crohn's disease targets. Genentech was an early investor in the company and 23andme recently hired Richard Scheller, former head of research and development at Genentech, to run this new program.
With regard to Denali, while maybe there will be some cooperation, they will now be a competitor of Genetech. In any case, its great news as the management team at the company is made up of world class scientists and executives, all with a devotion to treat and cure neurological diseases.